ASX:ANR

Anatara Lifesciences Competitors

Add
Compare
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
Volume3,950 shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Competitors

Anatara Lifesciences (ASX:ANR) Vs. CHV, DDXS, PREV, TNGN, COM, and MYM

Should you be buying ANR stock or one of its competitors? Companies in the industry of "biotechnology" are considered alternatives and competitors to Anatara Lifesciences, including (CHV) (CHV), (DDXS) (DDXS), (PREV) (PREV), (TNGN) (TNGN), 138267 (COM.TO) (COM), and 17031 (MYM).

(CHV) (CNSX:CHV) and Anatara Lifesciences (ASX:ANR) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, institutional ownership, valuation, dividends, risk, analyst recommendations and earnings.

Earnings and Valuation

This table compares (CHV) and Anatara Lifesciences' gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
(CHV)N/AN/AN/AN/AN/A
Anatara Lifesciences$268,259.000.00$-3,240,695.58A($0.05)N/A

(CHV) has higher earnings, but lower revenue than Anatara Lifesciences.

Analyst Recommendations

This is a summary of current ratings and recommmendations for (CHV) and Anatara Lifesciences, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
(CHV)0000N/A
Anatara Lifesciences0000N/A

Profitability

This table compares (CHV) and Anatara Lifesciences' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
(CHV)N/AN/AN/A
Anatara LifesciencesN/AN/AN/A

Summary

Anatara Lifesciences beats (CHV) on 1 of the 1 factors compared between the two stocks.

Anatara Lifesciences (ASX:ANR) and (DDXS) (OTCMKTS:DDXS) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, dividends, risk, institutional ownership, valuation, profitability and analyst recommendations.

Earnings and Valuation

This table compares Anatara Lifesciences and (DDXS)'s revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Anatara Lifesciences$268,259.000.00$-3,240,695.58A($0.05)N/A
(DDXS)N/AN/AN/AN/AN/A

(DDXS) has lower revenue, but higher earnings than Anatara Lifesciences.

Analyst Recommendations

This is a summary of current ratings for Anatara Lifesciences and (DDXS), as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Anatara Lifesciences0000N/A
(DDXS)0000N/A

Profitability

This table compares Anatara Lifesciences and (DDXS)'s net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Anatara LifesciencesN/AN/AN/A
(DDXS)N/AN/AN/A

Summary

Anatara Lifesciences beats (DDXS) on 1 of the 1 factors compared between the two stocks.

(PREV) (CNSX:PREV) and Anatara Lifesciences (ASX:ANR) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their valuation, profitability, institutional ownership, risk, earnings, dividends and analyst recommendations.

Analyst Ratings

This is a breakdown of recent recommendations and price targets for (PREV) and Anatara Lifesciences, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
(PREV)0000N/A
Anatara Lifesciences0000N/A

Profitability

This table compares (PREV) and Anatara Lifesciences' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
(PREV)N/AN/AN/A
Anatara LifesciencesN/AN/AN/A

Earnings & Valuation

This table compares (PREV) and Anatara Lifesciences' top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
(PREV)N/AN/AN/AN/AN/A
Anatara Lifesciences$268,259.000.00$-3,240,695.58A($0.05)N/A

(PREV) has higher earnings, but lower revenue than Anatara Lifesciences.

Summary

Anatara Lifesciences beats (PREV) on 1 of the 1 factors compared between the two stocks.

Anatara Lifesciences (ASX:ANR) and (TNGN) (OTCMKTS:TNGN) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, institutional ownership, risk, valuation, dividends and profitability.

Profitability

This table compares Anatara Lifesciences and (TNGN)'s net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Anatara LifesciencesN/AN/AN/A
(TNGN)N/AN/AN/A

Earnings & Valuation

This table compares Anatara Lifesciences and (TNGN)'s gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Anatara Lifesciences$268,259.000.00$-3,240,695.58A($0.05)N/A
(TNGN)N/AN/AN/AN/AN/A

(TNGN) has lower revenue, but higher earnings than Anatara Lifesciences.

Analyst Recommendations

This is a summary of current ratings and recommmendations for Anatara Lifesciences and (TNGN), as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Anatara Lifesciences0000N/A
(TNGN)0000N/A

Summary

Anatara Lifesciences beats (TNGN) on 1 of the 1 factors compared between the two stocks.

Anatara Lifesciences (ASX:ANR) and 138267 (COM.TO) (TSE:COM) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, analyst recommendations, risk, earnings, institutional ownership, profitability and dividends.

Profitability

This table compares Anatara Lifesciences and 138267 (COM.TO)'s net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Anatara LifesciencesN/AN/AN/A
138267 (COM.TO)N/AN/AN/A

Earnings and Valuation

This table compares Anatara Lifesciences and 138267 (COM.TO)'s gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Anatara Lifesciences$268,259.000.00C$-3,240,695.58A($0.05)N/A
138267 (COM.TO)N/AN/AN/AN/AN/A

138267 (COM.TO) has lower revenue, but higher earnings than Anatara Lifesciences.

Analyst Ratings

This is a breakdown of current recommendations for Anatara Lifesciences and 138267 (COM.TO), as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Anatara Lifesciences0000N/A
138267 (COM.TO)0000N/A

Summary

Anatara Lifesciences beats 138267 (COM.TO) on 1 of the 1 factors compared between the two stocks.

Anatara Lifesciences (ASX:ANR) and 17031 (CNSX:MYM) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their dividends, analyst recommendations, earnings, institutional ownership, valuation, profitability and risk.

Profitability

This table compares Anatara Lifesciences and 17031's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Anatara LifesciencesN/AN/AN/A
17031N/AN/AN/A

Valuation and Earnings

This table compares Anatara Lifesciences and 17031's gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Anatara Lifesciences$268,259.000.00C$-3,240,695.58A($0.05)N/A
17031N/AN/AN/AN/AN/A

17031 has lower revenue, but higher earnings than Anatara Lifesciences.

Analyst Recommendations

This is a breakdown of current recommendations and price targets for Anatara Lifesciences and 17031, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Anatara Lifesciences0000N/A
170310000N/A

Summary

Anatara Lifesciences beats 17031 on 1 of the 1 factors compared between the two stocks.


Anatara Lifesciences Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
CHV
(CHV)
0.5N/AN/A$0.00N/A0.00High Trading Volume
(DDXS) logo
DDXS
(DDXS)
0.5$0.00flat$0.00N/A0.00
PREV
(PREV)
0.7N/AN/A$0.00N/A0.00High Trading Volume
TNGN
(TNGN)
0.4N/AN/A$0.00N/A0.00Gap Up
COM
138267 (COM.TO)
0.5N/AN/AC$0.00N/A0.00
MYM
17031
0.4N/AN/AC$0.00N/A0.00
Abattis Bioceuticals logo
ATTBF
Abattis Bioceuticals
0.4$0.02flat$0.00N/A0.00
Abzena logo
ABZA
Abzena
0.6N/AN/A£0.00N/A0.00
ACHL
Achilles Therapeutics plc American Depositary Shares
0.0$13.78flat$0.00N/A0.00Gap Down
ACR
Acrux
0.9N/AN/A$0.00$1.61 million0.00High Trading Volume
Gap Up
ACW
Actinogen Medical
0.5N/AN/A$0.00$2.84 million0.00High Trading Volume
Gap Up
1AD
AdAlta
0.5N/AN/A$0.00$4.23 million0.00High Trading Volume
Gap Up
ADiTx Therapeutics logo
ADTX
ADiTx Therapeutics
1.0$2.94flat$0.00N/A0.00
AHZ
Admedus
0.5N/AN/A$0.00N/A0.00High Trading Volume
Algernon Pharmaceuticals logo
AGNPF
Algernon Pharmaceuticals
0.0$0.15flat$0.00N/A0.00News Coverage
Gap Down
Almirall logo
LBTSF
Almirall
0.5$15.00flat$0.00N/A0.00
AMBS
Amarantus BioScience
0.5N/AN/A$0.00N/A0.00High Trading Volume
ATX
Amplia Therapeutics
0.8N/AN/A$0.00$894,155.000.00High Trading Volume
Gap Up
ANVS
Annovis Bio
0.0N/AN/A$0.00N/A0.00High Trading Volume
Apotheca Biosciences logo
CBDC
Apotheca Biosciences
0.4$0.08flat$0.00N/A0.00
ARNI
Arno Therapeutics
0.5$0.01flat$0.00N/A0.00
ASCLF
Ascletis Pharma
0.4$0.37flat$0.00N/A0.00
Avid Bioservices logo
CDMOP
Avid Bioservices
0.3$25.06flat$0.00N/A0.00
AXIM Biotechnologies logo
AXIM
AXIM Biotechnologies
0.4$0.65flat$0.00N/A0.00News Coverage
Gap Up
BXRXV
Baudax Bio
0.5N/AN/A$0.00N/A0.00High Trading Volume
BRRGF
BerGenBio ASA
0.7$3.52flat$0.00N/A0.00
BGT
Bio-Gene Technology
0.8N/AN/A$0.00$82,795.000.00High Trading Volume
Gap Up
BNO
Bionomics
0.5N/AN/A$0.00$2.19 million0.00High Trading Volume
News Coverage
Gap Up
BIT
Biotron
0.5N/AN/A$0.00$853,026.000.00High Trading Volume
Gap Up
BXN
Bioxyne
0.5N/AN/A$0.00$2.18 million0.00High Trading Volume
Gap Up
BOT
Botanix Pharmaceuticals
0.5N/AN/A$0.00$6.89 million0.00High Trading Volume
Gap Up
BPH
BPH Energy
0.5N/AN/A$0.00$106,954.000.00High Trading Volume
News Coverage
Gap Up
BTC
BTC Health
0.8N/AN/A$0.00$131,934.000.00High Trading Volume
Gap Up
Cannabics Pharmaceuticals logo
CNBX
Cannabics Pharmaceuticals
0.4$0.25flat$0.00N/A0.00
ORHOF
CannaRoyalty
0.7$9.23flat$0.00N/A0.00Gap Down
CDXI
Cardax
0.0N/AN/A$0.00N/A0.00High Trading Volume
CDY
Cellmid
0.5N/AN/A$0.00$6.61 million0.00High Trading Volume
Gap Up
Cerebain Biotech logo
CBBT
Cerebain Biotech
0.0$0.06flat$0.00N/A0.00Gap Up
CHM
Chimeric Therapeutics
0.3N/AN/A$0.00N/A0.00High Trading Volume
CGYG
China Longyi Group International
0.4$0.00flat$0.00N/A0.00
CLVLY
Clinuvel Pharmaceuticals
1.0$22.86flat$0.00N/A0.00
CUV
Clinuvel Pharmaceuticals
1.0N/AN/A$0.00$38.34 million0.00High Trading Volume
Gap Up
CELZ
Creative Medical Technology
0.5$0.05flat$0.00N/A0.00Gap Up
CSL logo
CSL
CSL
0.8N/AN/A$0.00$9.98 billion0.00High Trading Volume
Gap Up
Cybin logo
CLXPF
Cybin
1.0$1.34flat$0.00N/A0.00Gap Up
CYP
Cynata Therapeutics
0.5N/AN/A$0.00$2.59 million0.00High Trading Volume
News Coverage
Gap Up
CURE
Direxion Daily Healthcare Bull 3X Shares
0.5N/AN/A$0.00N/A0.00High Trading Volume
News Coverage
Gap Down
Eastgate Biotech logo
ETBI
Eastgate Biotech
0.5$0.00flat$0.00N/A0.00High Trading Volume
EMMBF
Emblem
0.6$1.40flat$0.00N/A0.00
ENZC
Enzolytics
0.0$0.23flat$0.00N/A0.00Gap Up
This page was last updated on 4/11/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.